KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 75 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $150,000 | -3.8% | 16,000 | 0.0% | 0.03% | -3.6% |
| Q3 2016 | $156,000 | +290.0% | 16,000 | +166.7% | 0.03% | +250.0% |
| Q2 2016 | $40,000 | -25.9% | 6,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $54,000 | -32.5% | 6,000 | 0.0% | 0.01% | -46.7% |
| Q4 2015 | $80,000 | +15.9% | 6,000 | 0.0% | 0.02% | +25.0% |
| Q3 2015 | $69,000 | +27.8% | 6,000 | +200.0% | 0.01% | +33.3% |
| Q2 2015 | $54,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |